A detailed history of Campbell Newman Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Campbell Newman Asset Management Inc holds 62,327 shares of LLY stock, worth $46.6 Million. This represents 4.4% of its overall portfolio holdings.

Number of Shares
62,327
Previous 62,402 0.12%
Holding current value
$46.6 Million
Previous $56.5 Million 2.27%
% of portfolio
4.4%
Previous 4.62%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $57,910 - $72,001
-75 Reduced 0.12%
62,327 $55.2 Million
Q2 2024

Jul 18, 2024

SELL
$724.87 - $909.04 $1.19 Million - $1.49 Million
-1,635 Reduced 2.55%
62,402 $56.5 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $232,734 - $311,366
-393 Reduced 0.61%
64,037 $49.8 Million
Q4 2023

Jan 24, 2024

SELL
$525.19 - $619.13 $327,193 - $385,717
-623 Reduced 0.96%
64,430 $37.6 Million
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $10.1 Million - $14 Million
-23,294 Reduced 26.37%
65,053 $34.9 Million
Q2 2023

Jul 24, 2023

BUY
$350.74 - $468.98 $181,332 - $242,462
517 Added 0.59%
88,347 $41.4 Million
Q1 2023

Apr 28, 2023

SELL
$310.63 - $364.82 $109,652 - $128,781
-353 Reduced 0.4%
87,830 $30.2 Million
Q4 2022

Jan 26, 2023

BUY
$321.55 - $374.67 $170,743 - $198,949
531 Added 0.61%
88,183 $0
Q3 2022

Oct 27, 2022

SELL
$296.48 - $337.87 $81,828 - $93,252
-276 Reduced 0.31%
87,652 $28.3 Million
Q2 2022

Jul 19, 2022

BUY
$278.73 - $327.27 $1.27 Million - $1.49 Million
4,555 Added 5.46%
87,928 $28.5 Million
Q1 2022

Apr 27, 2022

SELL
$234.69 - $291.66 $57,264 - $71,165
-244 Reduced 0.29%
83,373 $23.9 Million
Q4 2021

Jan 24, 2022

BUY
$224.85 - $279.04 $12,366 - $15,347
55 Added 0.07%
83,617 $23.1 Million
Q3 2021

Oct 15, 2021

SELL
$221.6 - $272.71 $3.79 Million - $4.66 Million
-17,083 Reduced 16.97%
83,562 $19.3 Million
Q2 2021

Jul 16, 2021

BUY
$180.55 - $233.54 $72,761 - $94,116
403 Added 0.4%
100,645 $23.1 Million
Q1 2021

Apr 19, 2021

BUY
$164.32 - $212.72 $231,033 - $299,084
1,406 Added 1.42%
100,242 $18.7 Million
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $246,047 - $325,580
1,886 Added 1.95%
98,836 $16.7 Million
Q3 2020

Oct 20, 2020

BUY
$146.22 - $169.13 $24,857 - $28,752
170 Added 0.18%
96,950 $14.4 Million
Q2 2020

Jul 27, 2020

BUY
$136.42 - $164.18 $194,262 - $233,792
1,424 Added 1.49%
96,780 $15.9 Million
Q1 2020

Apr 27, 2020

BUY
$119.05 - $147.35 $4,523 - $5,599
38 Added 0.04%
95,356 $13.2 Million
Q4 2019

Jan 22, 2020

BUY
$106.92 - $132.43 $33,145 - $41,053
310 Added 0.33%
95,318 $12.5 Million
Q3 2019

Oct 23, 2019

BUY
$106.79 - $116.16 $226,928 - $246,840
2,125 Added 2.29%
95,008 $10.6 Million
Q2 2019

Jul 24, 2019

BUY
$110.79 - $129.32 $195,765 - $228,508
1,767 Added 1.94%
92,883 $10.3 Million
Q1 2019

Apr 09, 2019

BUY
$111.31 - $131.02 $7.21 Million - $8.49 Million
64,800 Added 246.24%
91,116 $11.8 Million
Q2 2017

Aug 09, 2017

BUY
N/A
26,316
26,316 $2.17 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Campbell Newman Asset Management Inc Portfolio

Follow Campbell Newman Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Newman Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Newman Asset Management Inc with notifications on news.